Kinetic Profile and Molecular Dynamic Studies Show that Y229W Substitution in an NDM-1/L209F Variant Restores the Hydrolytic Activity of the Enzyme toward Penicillins, Cephalosporins, and Carbapenems.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
04 2019
Historique:
received: 27 10 2018
accepted: 23 01 2019
entrez: 29 3 2019
pubmed: 29 3 2019
medline: 27 2 2020
Statut: epublish

Résumé

The New Delhi metallo-β-lactamase-1 (NDM-1) enzyme is the most common metallo-β-lactamase identified in many Gram-negative bacteria causing severe nosocomial infections. The aim of this study was to focus the attention on non-active-site residues L209 and Y229 of NDM-1 and to investigate their role in the catalytic mechanism. Specifically, the effect of the Y229W substitution in the L209F variant was evaluated by antimicrobial susceptibility testing, kinetic, and molecular dynamic (MD) studies. The Y229W single mutant and L209F-Y229W double mutant were generated by site-directed mutagenesis. The

Identifiants

pubmed: 30917978
pii: AAC.02270-18
doi: 10.1128/AAC.02270-18
pmc: PMC6437508
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0
Cephalosporins 0
Penicillins 0
beta-Lactamases EC 3.5.2.6
beta-lactamase NDM-1 EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Future Med Chem. 2018 Jan;10(2):221-229
pubmed: 29202600
FASEB J. 2011 Aug;25(8):2574-82
pubmed: 21507902
J Comput Aided Mol Des. 2000 Feb;14(2):123-34
pubmed: 10721501
Nat Commun. 2017 Sep 14;8(1):538
pubmed: 28912448
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29038264
J Am Chem Soc. 2012 Jul 18;134(28):11362-5
pubmed: 22713171
Mol Biol Evol. 2016 Jul;33(7):1768-76
pubmed: 26983555
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2366-72
pubmed: 26856833
PLoS One. 2013 Dec 10;8(12):e82080
pubmed: 24339993
Antimicrob Agents Chemother. 2004 Jul;48(7):2347-9
pubmed: 15215079
J Comput Chem. 2005 Dec;26(16):1701-18
pubmed: 16211538
Lancet Infect Dis. 2010 Sep;10(9):597-602
pubmed: 20705517
Antimicrob Agents Chemother. 2008 Mar;52(3):915-9
pubmed: 18160520
J Antimicrob Chemother. 2008 Nov;62(5):991-7
pubmed: 18755695
Int J Infect Dis. 2016 Feb;43:17-20
pubmed: 26686939
Protein Cell. 2011 May;2(5):384-94
pubmed: 21637961
Antimicrob Agents Chemother. 2018 Oct 24;62(11):
pubmed: 30150473
J Biol Chem. 2018 Aug 10;293(32):12606-12618
pubmed: 29909397
J Antimicrob Chemother. 2012 Jul;67(7):1645-50
pubmed: 22511638
Nat Chem Biol. 2016 Jul;12(7):516-22
pubmed: 27182662
BMC Microbiol. 2017 Apr 27;17(1):101
pubmed: 28449650
Nat Commun. 2017 Dec 21;8(1):2242
pubmed: 29269938
Mol Biol Evol. 2015 Jul;32(7):1774-87
pubmed: 25767204
Protein Sci. 2011 Sep;20(9):1484-91
pubmed: 21774017
FASEB J. 2013 May;27(5):1917-27
pubmed: 23363572
PLoS One. 2012;7(4):e34752
pubmed: 22511964
Nat Methods. 2011 Sep 29;8(10):785-6
pubmed: 21959131
J Antimicrob Chemother. 2018 Jun 1;73(6):1517-1524
pubmed: 29518198
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29784851
Microb Drug Resist. 2016 Mar;22(2):123-8
pubmed: 26484384
Antimicrob Agents Chemother. 2015 Oct;59(10):6597-600
pubmed: 26169417
Int J Antimicrob Agents. 2018 Dec;52(6):906-909
pubmed: 29958975
PLoS One. 2018 Jan 2;13(1):e0189686
pubmed: 29293526
Biomed Res Int. 2014;2014:249856
pubmed: 24790993
J Glob Antimicrob Resist. 2018 Sep;14:154-157
pubmed: 29656053
Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54
pubmed: 19770275
FEMS Microbiol Lett. 2017 Apr 1;364(8):
pubmed: 28333234

Auteurs

Alessandra Piccirilli (A)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy.

Fabrizia Brisdelli (F)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy.

Massimiliano Aschi (M)

Dipartimento di Scienze Fisiche e Chimiche, Università degli Studi dell'Aquila, L'Aquila, Italy.

Giuseppe Celenza (G)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy.

Gianfranco Amicosante (G)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy.

Mariagrazia Perilli (M)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy perilli@univaq.it.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Classifications MeSH